Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction
Disclaimer: Publications may either be freely available or require a fee to view (or access) on the journal’s website.
Full Citation
Kernan WN, Viscoli CM, Dearborn JL, Kent DM, Conwit R, Fayad P, Furie KL,
Gorman M, Guarino PD, Inzucchi SE, Stuart A, Young LH; Insulin Resistance
Intervention After Stroke (IRIS) Trial Investigators. Targeting Pioglitazone
Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to
Pretreatment Risk for Stroke or Myocardial Infarction. JAMA Neurol. 2017 Sep 18.
doi: 10.1001/jamaneurol.2017.2136. [Epub ahead of print] PubMed PMID: 28975241.
Tags
Journal Article Type
- Paper Resulting From PCORI-Funded Research Study (with results)
- CER Results
Journal Publication Name
- JAMA Neurology
Literature Type
- PCORI Research